The National Society of Pharmaceutical Sales Trainers has increased its partnership and service to the pharmaceutical sales industry by offering two excellent training workshops to member companies.
The National Society of Pharmaceutical Sales Trainers has increased its partnership and service to the pharmaceutical sales industry by offering two excellent training workshops to member companies.
During 1997, the NSPST conducted six Train-the-Trainer workshops and three Coaching for Improved Performance seminars. Industry response to these course offerings was so positive that NSPST has increased the frequency of these workshops for 1998.
The NSPST Train-the-Trainer workshop can be a valuable tool for pharmaceutical companies promoting sales representatives into their sales training departments. The basic four-day course is a participation workshop that focuses on methods necessary to promote effective adult learning. The workshop emphasizes interaction, student involvement and feedback.
In response to requests from numerous companies, NSPST developed Coaching for Improved Performance in 1997. A total of 90 sales managers and trainers attended the seminar, which taught face-to-face coaching techniques that improve the performance of individuals and teams. The workshops were limited to 20 participants.
Both the Train the Trainer and Coaching for Improved Performance programs are available to individuals during scheduled public seminars. They are also available to companies for private seminars for their employees.
To register for a public seminar or schedule a session for your company, call the NSPST business office at (860) 675-1824. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.